William G. Kaelin
- Cancer Research top 0.01%
- Cancer, Hypoxia, and Metabolism 124
- Oncology top 0.05%
- Cancer-related Molecular Pathways 72
- Molecular Biology top 0.02%
- Epigenetics and DNA Methylation 47
- Ubiquitin and proteasome pathways 36
- RNA modifications and cancer 35
- Biotechnology top 0.05%
- Cancer Research and Treatments 23
- Genetics top 0.1%
- Virus-based gene therapy research 19
-
- Renal cell carcinoma treatment 17
- Co-authors
- Peter J. RatcliffeMircea IvanKeiichi KondoMichael OhhOthon IliopoulosDavid M. LivingstonHaifeng YangWilliam Y. Kim
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
William G. Kaelin
243 papers receiving 49.4k citations
Hit Papers
Peers
Comparison fields: 5 of 168
- Cancer Research 22.6k
- Oncology 14.8k
- Molecular Biology 35.6k
- Biotechnology 2.5k
- Genetics 6.0k
Countries citing papers authored by William G. Kaelin
This map shows the geographic impact of William G. Kaelin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William G. Kaelin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William G. Kaelin more than expected).
Fields of papers citing papers by William G. Kaelin
This network shows the impact of papers produced by William G. Kaelin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William G. Kaelin. The network helps show where William G. Kaelin may publish in the future.
Co-authorship network
The 25 scholars most cited alongside William G. Kaelin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 6 | |
| 3 | 2022 | 70 | |
| 4 | 2022 | 21 | |
| 5 | 2019 | 22 | |
| 6 | Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fatebreakdown → | 2019 | 280 |
| 7 | 2017 | 36 | |
| 8 | EGLN1 Inhibition and Rerouting of α-Ketoglutarate Suffice for Remote Ischemic Protection | 2016 | 1 |
| 9 | 2015 | 116 | |
| 10 | ( R )-2-Hydroxyglutarate Is Sufficient to Promote Leukemogenesis and Its Effects Are Reversiblebreakdown → | 2013 | 533 |
| 11 | The Myeloma Drug Lenalidomide Promotes the Cereblon-Dependent Destruction of Ikaros Proteinsbreakdown → | 2013 | 1108 |
| 12 | Genetic and Functional Studies Implicate HIF1 α as a 14q Kidney Cancer Suppressor Genebreakdown → | 2011 | 313 |
| 13 | 2010 | 48 | |
| 14 | 2010 | 116 | |
| 15 | Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidneybreakdown → | 2009 | 310 |
| 16 | 2007 | 154 | |
| 17 | 2005 | 238 | |
| 18 | 2004 | 181 | |
| 19 | 1999 | 86 | |
| 20 | 1997 | 32 |
About William G. Kaelin
William G. Kaelin is a scholar working on Cancer Research, Oncology and Biotechnology, having authored 246 papers that have together received 50.2k indexed citations. Recurring topics across this work include Cancer, Hypoxia, and Metabolism (124 papers), Cancer-related Molecular Pathways (72 papers), Epigenetics and DNA Methylation (47 papers), Ubiquitin and proteasome pathways (36 papers), RNA modifications and cancer (35 papers), Cancer Research and Treatments (23 papers), Virus-based gene therapy research (19 papers) and Renal cell carcinoma treatment (17 papers). The work is most often cited by research in Cancer Research (22.6k citations), Oncology (14.8k citations) and Molecular Biology (35.6k citations). William G. Kaelin has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Peter J. Ratcliffe, Mircea Ivan, Keiichi Kondo, Michael Ohh, Othon Iliopoulos, David M. Livingston, Haifeng Yang, William Y. Kim, William R. Sellers and Nikola P. Pavletich. Their work appears in journals such as Nature, Science and Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.